Flatiron Health is a New York-based oncology technology company, majority-owned by Roche, that combines real-world data, AI, and clinical software to accelerate cancer research and improve patient care. Its two main pillars are a provider-facing oncology software suite (OncoCloud) and a life sciences data and research platform. OncoCloud includes OncoEMR (an oncology-specific electronic health record), OncoBilling, OncoAnalytics, and Flatiron Telescope (a newly launched AI platform that delivers oncology insights in minutes from its dataset of millions of real-world cancer patient records.) On the research side, Flatiron licenses curated, de-identified real-world oncology data to biopharma companies, regulators, and academic institutions, and its data has informed more than 2,000 published studies. It is designed for community oncology practices, cancer centers, academic medical centers, and pharmaceutical and biotech companies conducting research and clinical trials, not individual clinicians. Pricing is not publicly listed and is enterprise-quoted through sales, varying based on whether the customer is a provider using the software suite or a life sciences company licensing research data.
Leave a Reply